Skip to main content
Clinical Trials/NCT01726010
NCT01726010
Unknown
Not Applicable

Endoscopic Ultrasound Guided Biopsy of Subepithelial Tumors of the Upper Gastrointestinal Tract Using the 22-G-Procore Needle

Technical University of Munich1 site in 1 country20 target enrollmentSeptember 2012

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Subepithelial Tumors of the Upper Gastrointestinal Tract
Sponsor
Technical University of Munich
Enrollment
20
Locations
1
Primary Endpoint
diagnostic yield
Last Updated
13 years ago

Overview

Brief Summary

The goal of this prospective study is to evaluate the feasibility of the 22-G Core Biopsy Needle with reverse bevel (Procore TM) in biopsy sampling of subepithelial tumors of the upper gastrointestinal tract.

Registry
clinicaltrials.gov
Start Date
September 2012
End Date
October 2013
Last Updated
13 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Technical University of Munich
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patient age 18 years and older
  • All patients with subepithelial tumors of the upper GI tract (maximum size: 3 cm)

Exclusion Criteria

  • Unable to obtain informed consent
  • ASA class 4 or 5
  • known pregnancy
  • contraindication endoscopy
  • contraindication for taking biopsies

Outcomes

Primary Outcomes

diagnostic yield

Time Frame: 6 months

Number of patients with adequate tissue sample (which allows definitive diagnosis)

Study Sites (1)

Loading locations...

Similar Trials